Sanguinarine Disrupts Cell Cycle Regulation in Breast Cancer Cells
Author Information
Author(s): Holy Jon, Lamont Genelle, Perkins Edward
Primary Institution: University of Minnesota Medical School Duluth
Hypothesis
Does sanguinarine affect the trafficking of cyclin D1 and topoisomerase II in breast cancer cells?
Conclusion
Sanguinarine can suppress breast cancer cell proliferation by disrupting the trafficking of cyclin D1 and topoisomerase II.
Supporting Evidence
- Sanguinarine effectively inhibits MCF-7 proliferation after a single application.
- The relocalization of cyclin D1 and topoisomerase II from the nucleus to the cytoplasm occurs after treatment with sanguinarine.
- Sanguinarine transiently inhibits DNA synthesis in MCF-7 cells.
- Cells recover their ability to synthesize DNA within 24 hours after treatment.
Takeaway
Sanguinarine is a plant compound that can stop cancer cells from growing by moving important proteins out of the nucleus, which is where they usually work.
Methodology
MCF-7 breast cancer cells were treated with sanguinarine, and the effects on cyclin D1 and topoisomerase II were studied using immunocytochemical methods.
Limitations
The study did not quantify apoptosis and focused primarily on the effects of sanguinarine on cell proliferation.
Participant Demographics
MCF-7 breast cancer cells were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website